Failure of alkylating agents to improve induction chemotherapy of oropharyngeal squamous cell cancer

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2557-2561

  Olasz, Lajos ^a,b   Nyárády, Zoltán ^a   Németh, Árpád ^a   Királyfalvi, László ^a   Ember, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE   (Hungary)

Author keywords

Alkylating drugs; Head and neck cancer; Induction chemotherapy; Oropharyngeal cancer

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FOLINATE CALCIUM; METHOTREXATE; MITOLACTOL; ONDANSETRON; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTRITIS; HUMAN; IMMUNE DEFICIENCY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MITOLACTOL; OROPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT FAILURE; VINCRISTINE;

EID: 4444301127     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gaudi I and Kásler M: The course of cancer mortality in Hungary between 1975 and 2001 (English abstract). Magy Onk 46: 291-295, 2002.
2. Hamakawa H, Bao Y, Takarada M and Tanioka H: Histological effects and predictive biomarkers of TTP induction chemotherapy for oral carcinoma. J Oral Pathol Med 27: 87-94, 1998.
3. Jeney A, Kralovánszky J and Katona Cs: Changing strategy and increasing possibilities in the cytostatic therapy of cancers (English abstract). Magy Onk 43: 3-10, 1999.
4. Szabó Gy: New steps in the intra-arterial chemotherapy of head and neck tumors. Oncology 42: 217-223, 1985.
5. Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G et al: Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer 91: 1316-1323, 2001.
6. Dunphy FR, Dunleavy TL, Harrison BR, Trinkaus KM, Kim HJ, Stack BC Jr et al: Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 and 1999. Cancer 91(5): 940-948, 2001.
7. Olasz L, Szabó I and Horváth A: A combined treatment for advanced oral cavity cancers. Cancer 62: 1267-1274, 1988.
8. Olasz L, Kwashie F and Herczegh P: A comparative study of preoperative BVMM chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity. Neoplasma 43: 53-56, 1996.
9. Olasz L, Nyárády Z, Németh Á, Rónai A and Gelencsér G: Regional failure related to alkylating agents in neoadjuvant chemotherapy of the oropharyngeal planocellular cancer. J Craniomaxillofac Surg 30(Suppl 1): 54, 2002.
10. Cox DR: Regression models and lifetables. J R Stat Soc B 34: 187-220, 1972.
11. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
12. Schmee F and Hanks GF: A simple method for regression analysis with censored data. Technometrics 21: 417-432, 1979.
13. Wieand HS: Application of nonparametric statistics to cancer data. Handbook of Statistics 4: 771-790, 1984.
14. Zidan J, Kuten A, Rosenblatt E and Robinson E: Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Oral Oncol 33: 129-135, 1997.
15. Grau JJ, Estape J, Blanch JL, Vilalta A, Castro V, Biete A et al: Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV. Eur J Cancer B Oral Oncol 32: 238-241, 1996.
16. Vokes EE, Mick R, Lester EP, Panje WR and Weichselbaum RR: Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution. J Clin Onc 9: 1376-1384, 1991.
17. Price LA and Hill BT: Safe and effective combination chemotherapy for squamous cell carcinomas of the head and neck. J Laryngol Otol 94: 89-90, 1980.
18. Athanasiadis J, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB et al: Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Cancer 79: 588-594, 1997.
19. Grégoire V, Beauduin M, Humblet Y, Hamoir M, Longueville J, Majois F et al: A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: Report from the UCL-Oncology Group, Belgium. J Clin Oncol 9: 1385-1392, 1991.
20. Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Nat Canc Inst 86: 265-272, 1994.
21. Price LA and Hill BT: Impact of primary site Stage III and IV squamous cell carcinomas of the head and neck on 7-year survival figures following initial noncisplatin-containing combination chemotherapy. Rec Res Cancer Res 103: 124-134, 1986.
22. Wada T, Harada T, Morita N, Oomata T, Koizumi T, Kawashima T et al: Chemotherapy administered using two-route infusion of cisplatin and sodium thiosulfate and intravenous infusion of vinblastine and peplomycine in patients with oral cancer. Clin Ther 17: 280-289, 1995.
23. Wilson WR, Siegel RS, Harasiadis LA, Davis DO, Nguyen HH and Bank WO: High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 809-812, 2001.
24. Olasz L, Németh Á, Nyárády Z, Tornóczky T and Királyfalvi L: A randomized study of cisplatin-containing chemotherapy for treatment of head-neck planocellular cancer (English abstract). Orv Hetil 141(45): 2433-2437, 2000.
25. Jakobs C and Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the head and neck contracts program. J Clin Onc 8: 838-847, 1999.
26. Vokes EE, Merrill K, Haraf DJ, Mick R, Moran WJ, Kozloff M et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Onc 13: 876-883, 1995.
27. Mohr C, Bohndorf W, Carstens J, Harle F, Hausamen JE, Hirche H et al: Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective multicentric randomized DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow up). Int J Oral Maxillofac Surg 23: 140-148, 1994.
28. Okura M, Hiranuma T, Adachi T, Ogura T, Aikawa T, Yoshioka H et al: Induction chemotherapy is associated with increase in the evidence of locoregional recurrence in patients with carcinoma of the oral cavity: Results from a single institution. Cancer 82: 804-815, 1998.
29. Chambers SK, Chopyk RL, Chambers JT, Schwartz PE and Duffy TP: Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer. Cancer 64: 2459-2461, 1989.
30. Ferrari C, Bohling T, Benassi MS, Ferraro A, Gamberi G, Bacci G et al: Secondary tumors in bone sarcomas after treatment with chemotherapy. Cancer Detect Prev 23: 368-374, 1999.
31. Mantz CA, Vokes EE, Stenson K, Klies MS, Mittal B, Witt ME et al: Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. Cancer J 7(2): 140-148, 2001.
32. Eckhardt A, Rades D, Rudat V, Hofeele C, Dammer R, Dietl R et al: Prospective phase study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome (English abstract). Mund Kiefer Gesichtschir 6(2): 117-121, 2002.